PMVAX
Putnam Sustainable Future-A
Introduction to Putnam Sustainable Future-A
Putnam Sustainable Future-A (PMVAX) is a mutual fund designed to achieve capital appreciation with a secondary focus on current income. It primarily invests in common stocks of U.S. firms across various sizes, with a particular emphasis on midcap growth opportunities. Managed by Franklin Templeton Investments, this fund is tailored for investors seeking a blend of growth and income, with a sustainable investment approach. The fund’s strategy is to identify companies that not only have strong growth potential but also adhere to sustainable business practices, making it an attractive option for socially conscious investors.
At A Glance
Executive Summary
PMVAX offers sustainable growth with a focus on US midcap stocks, featuring a diverse sector allocation and competitive returns.
Focus on sustainable investments Diverse sector allocation Competitive midcap growth returns
Higher expense ratio Negative recent performance Limited income yield
Performance Analysis: A Year of Growth
In the past year, PMVAX has delivered a remarkable 37.15% return, closely aligning with its benchmark, the S&P 500 Total Return Index, which posted a 37.62% return. This performance highlights the fund’s ability to capture growth in a volatile market environment. However, when compared to similar funds like Virtus Silvant MidCap Growth-A and American Century Heritage-A, which achieved returns of 44.04% and 45.83% respectively, PMVAX slightly underperformed. Despite this, its focus on sustainable investments provides a unique value proposition that may appeal to investors prioritizing environmental, social, and governance (ESG) criteria.
Sector Allocation: A Diverse Portfolio
PMVAX boasts a well-diversified sector allocation, with significant investments in technology (25.87%), healthcare (21.43%), and industrials (15.36%). This diversification helps mitigate risks associated with sector-specific downturns while capitalizing on growth opportunities across various industries. The fund’s minimal exposure to energy and basic materials sectors reflects its commitment to sustainable investing, avoiding industries with higher environmental impact. This strategic allocation not only supports the fund’s growth objectives but also aligns with the increasing demand for ESG-focused investment solutions.
Risk Metrics: Understanding Volatility
The risk profile of PMVAX is characterized by a beta of 1.13, indicating a slightly higher volatility compared to the market. The fund’s alpha of -0.51% and Sharpe ratio of -0.03 suggest that it has faced challenges in delivering risk-adjusted returns. However, its R-squared value of 81.15% demonstrates a strong correlation with its benchmark, the S&P 500 Total Return Index. Investors should be aware of the fund’s downside risk, with a maximum drawdown of -9.3%, but also consider its potential for recovery, as evidenced by its quick recovery length of just one month.
Competitive Expense Ratio: A Consideration for Investors
With an expense ratio of 1.05%, PMVAX is positioned competitively within the midcap growth category, though it is higher than some of its peers like TRPrice Diversified MidCap Growth-Inv, which has an expense ratio of 0.86%. While the fund’s expense ratio may be a consideration for cost-conscious investors, it is important to weigh this against the fund’s sustainable investment strategy and its potential for long-term growth. The fund’s management by Franklin Templeton Investments, a reputable firm, adds an additional layer of confidence for investors.
Top Holdings: A Focus on Innovation
The top holdings of PMVAX include leading companies such as Roper Technologies Inc, Thermo Fisher Scientific Inc, and Intuitive Surgical Inc, each representing a significant portion of the fund’s portfolio. These companies are known for their innovative approaches and strong market positions, aligning with the fund’s objective of capital appreciation. The inclusion of such firms underscores the fund’s commitment to investing in businesses that are not only financially robust but also contribute positively to societal and environmental outcomes. This focus on innovation and sustainability is a key differentiator for PMVAX.
Market Cap Allocation: Emphasizing Midcap Growth
PMVAX’s market cap allocation is heavily weighted towards medium-sized companies, which constitute 41.64% of its portfolio. This focus on midcap stocks is consistent with the fund’s growth strategy, as these companies often offer a balance between stability and growth potential. The fund also maintains exposure to small-cap (20.50%) and large-cap (28.24%) stocks, providing a diversified approach to capturing growth across different market segments. This allocation strategy is designed to optimize returns while managing risk, making it suitable for investors seeking growth opportunities in the midcap space.
Conclusion: Is PMVAX Right for You?
Putnam Sustainable Future-A (PMVAX) stands out as a compelling option for investors interested in sustainable midcap growth opportunities. Its focus on ESG criteria, combined with a diverse sector allocation and a commitment to innovation, makes it an attractive choice for socially conscious investors. However, potential investors should consider the fund’s higher expense ratio and recent performance challenges. Overall, PMVAX is well-suited for those seeking a blend of growth and sustainability, particularly in the midcap sector, and who are willing to accept the associated risks for potential long-term rewards.
Similar Securities
JAAGX: Janus Henderson VIT Enterprise-Inst | MidCap Growth Fund Analysis
JAAGX offers mid-cap growth with a 0.72% expense ratio, focusing on equity securities. It provides a unique bottom-up investment approach.
LBGAX: ClearBridge MidCap Growth-A | MidCap Growth Investment
LBGAX offers a robust 39.67% 1-year return with a focus on mid-cap equities, outperforming its benchmark with a 2.00% alpha.
BSDAX: BlackRock Small/MidCap Growth Fund | High-Growth U.S. Equities
BSDAX offers exposure to high-growth U.S. small/mid-cap stocks with a focus on above-average earnings potential, despite higher volatility.
LBFIX: ClearBridge Select-I | High-Growth MidCap Equity Fund
LBFIX stands out with a 40.59% 1-year return and a tech-heavy portfolio, offering high growth potential for midcap investors.
FRSGX: Franklin Small/MidCap Growth-A | MidCap Growth Investment
FRSGX offers growth potential with a focus on small/mid-cap equities, boasting a 34% 1-year return. Competitive expense ratio of 0.86%.
Futher Reading
https://finance.yahoo.com/quote/PMVAX/”>Yahoo: Putnam Sustainable Future-A
Disclaimer: The information provided on this website is for informational purposes only and should not be construed as financial, investment, or other professional advice. PeepFinance does not endorse or recommend any specific securities, investments, or strategies. The opinions expressed are solely those of the authors and are not intended to be used as the basis for any investment decisions. All investments carry risks, and readers are encouraged to conduct their own research or consult with a financial professional before making any financial decisions. PeepFinance and its authors are not responsible for any losses or damages arising from the use of this information.